Exact Sciences Corp (NAS:EXAS)
$ 52.975 -0.545 (-1.02%) Market Cap: 9.78 Bil Enterprise Value: 11.92 Bil PE Ratio: 0 PB Ratio: 3.11 GF Score: 78/100

Exact Sciences Corp at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 07:30PM GMT
Release Date Price: $102.61 (+1.64%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Good afternoon, and thanks for joining us. Welcome to Jefferies 2019 Global Healthcare Conference. I'm Brandon Couillard, senior life sciences tools and diagnostics analyst here at the firm. Very happy to have Exact Sciences with us back at the conference this year. And here to share with us a brief update, CEO, Mr. Kevin Conroy. Then we will jump into some Q&A. Kevin?

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Thank you, sir. Thank you, Brandon, and thank you, Jefferies, for inviting us to present and thanks all of you for joining the presentation. It's always great to be at the Jefferies' conference especially when the weather is like it is in New York City. We will be making forward-looking statements. This is our safe harbor statement.

Our mission at Exact Sciences is to detect cancer earlier. That's being proven by our test Cologuard, and we're going to talk about Cologuard today, the importance of addressing the #2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot